Share on StockTwits

CAS Medical Systems (NASDAQ:CASM) CEO Thomas M. Patton purchased 10,000 shares of the company’s stock on the open market in a transaction that occurred on Friday, August 8th. The stock was purchased at an average price of $1.61 per share, for a total transaction of $16,100.00. Following the completion of the acquisition, the chief executive officer now directly owns 540,177 shares in the company, valued at approximately $869,685. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Shares of CAS Medical Systems (NASDAQ:CASM) traded up 3.23% during mid-day trading on Monday, hitting $1.60. 25,819 shares of the company’s stock traded hands. CAS Medical Systems has a 52-week low of $1.211 and a 52-week high of $2.50. The stock has a 50-day moving average of $1.89 and a 200-day moving average of $2.08. The company’s market cap is $30.7 million.

CAS Medical Systems (NASDAQ:CASM) last released its earnings data on Wednesday, August 6th. The company reported ($0.13) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.11) by $0.02. The company had revenue of $5.80 million for the quarter, compared to the consensus estimate of $5.00 million. Analysts expect that CAS Medical Systems will post $-0.48 EPS for the current fiscal year.

CAS Medical Systems, Inc (NASDAQ:CASM) is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products that is vital to patient care.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.